NCT05807074 2025-09-29
Impact of Topical Tranexamic Acid in Breast Reconstruction
University of California, San Francisco
Phase 4 Terminated
Clinical Trials
12 trialsNCT03360214 2025-06-15
PEMF and PEC Blocks in Mastectomy Reconstruction Patients
Columbia University
Phase 4 Completed
NCT02258451 2023-11-24
Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer
Bayer
Phase 2 Completed
NCT02513329 2023-06-05
Stellate Ganglion Block (SGB) For Women for Breast Cancer
Northwestern University
Phase 2 Completed
NCT03241810 2020-09-02
SHERBOC
Elevation Oncology
Phase 2 Terminated
NCT02258464 2020-08-10
Study of Radium-223 Dichloride Versus Placebo and Hormonal Treatment as Background Therapy in Subjects With Bone Predominant HER2 (Human Epidermal Growth Factor Receptor 2) Negative Hormone Receptor Positive Metastatic Breast Cancer
Bayer
Phase 2 Terminated
NCT01806259 2020-04-07
KBCt
Université Catholique de Louvain
Phase 3 Completed
NCT01591746 2019-10-10
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Mayo Clinic
Phase 3 Completed
NCT02525718 2019-08-14
Selective Intraoperative Administration of Local Anesthesia in Breast Reconstruction
Northwestern University
Phase 2 Completed
NCT01539317 2017-04-14
Therapy to Prevent Sexual Pain in Breast Cancer Survivors
OHSU Knight Cancer Institute
Phase 3 Completed
NCT01205503 2016-02-24
Trial of Mesna to Prevent Doxorubicin-induced Plasma Protein Oxidation and Tumor Necrosis Factor Alpha (TNF-α) Release
University of Kentucky
Phase 2 Completed
NCT00925548 2014-07-24
STRIDE
EMD Serono
Phase 3 Terminated